innervation
|
2.21
|
|
|
Larynx
|
|
2.22
|
|
|
Limb muscle innervation (myotomes)
|
|
2.23
|
|
|
Lumbar plexus
|
|
2.24
|
|
|
Nose
|
|
2.25
|
|
|
Orbit
|
|
2.26
|
|
|
Rib
|
|
2.27
|
|
|
Sacral plexus
|
|
2.28
|
|
|
Sacrum
|
|
2.29
|
|
|
Spinal nerve
|
|
2.30
|
|
|
Thoracic inlet and first rib
|
|
2.31
|
|
|
Vertebra
|
SECTION 3 PHARMACODYNAMICS AND KINETICS
|
3.1
|
|
|
Clearance
|
|
3.2
|
|
|
Compartment model – one and two compartments
|
|
3.3
|
|
|
Compartment model – three compartments
|
|
3.4
|
|
|
Dose–response curves
|
|
3.5
|
|
|
Elimination
|
|
3.6
|
|
|
Elimination kinetics
|
|
3.7
|
|
|
Half-lives and time constants
|
|
3.8
|
|
|
Meyer–Overton hypothesis
|
|
3.9
|
|
|
Volume of distribution
|
|
3.10
|
|
|
Wash-in curves for volatile agents
|
SECTION 4 DRUGS
|
4.1
|
|
|
Anaesthetic agents – etomidate
|
|
4.2
|
|
|
Anaesthetic agents – ketamine
|
|
4.3
|
|
|
Anaesthetic agents – propofol
|
|
4.4
|
|
|
Anaesthetic agents – thiopentone
|
|
4.5
|
|
|
Local anaesthetics – mode of action
|
|
4.6
|
|
|
Local anaesthetics – properties
|
|
4.7
|
|
|
Neuromuscular blockers – mode of action
|
|
4.8
|
|
|
Neuromuscular blocking agents – depolarizing
|
|
4.9
|
|
|
Neuromuscular blocking agents – non-depolarizing
|
|
4.10
|
|
|
Opioids – mode of action
|
|
4.11
|
|
|
Opioids – properties
|
|
4.12
|
|
|
Volatile anaesthetic agents – mode of action
|
|
4.13
|
|
|
Volatile anaesthetic agents – physiological effects
|
|
4.14
|
|
|
Volatile anaesthetic agents – properties
|
SECTION 5 PHYSICS
|
5.1
|
|
|
Avogadro’s law
|
|
5.2
|
|
|
Beer–Lambert law
|
